Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 12
Submit an article Journal homepage
542
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity

Kohei Kaku Diabetes and Endocrine Division, Department of Medicine, Kawasaki Medical School, Okayama, JapanCorrespondence[email protected]
,
Hiroyuki Daida Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan
,
Atsunori Kashiwagi Department of Medicine, Shiga University of Medical Science, Shiga, Japan
,
Akira Yamashina Second Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
,
Tsutomu Yamazaki Department of Clinical Epidemiology & Systems, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
,
Shin-ichi Momomura Saitama Medical Center, Jichi Medical University, Saitama, Japan
,
Takashi Iwase Iwase Internal Medicine Cardiology Clinic, Tokyo, Japan
,
Yoshimitsu Yamasaki Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
,
Kazuyuki Nagatsuka Cerebrovascular Division, Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
,
Kazuo Kitagawa Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
&
Ryuzo Kawamori Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan
 show all
Pages 2925-2932 | Accepted 11 Sep 2009, Published online: 16 Oct 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
A. Enrique Caballero. (2017) Long-term studies of treatments for type 2 diabetes. Postgraduate Medicine 129:3, pages 352-365.
Read now
Kohei Kaku, Kazuaki Enya, Kenkichi Sugiura & Nobuo Totsuka. (2011) Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus. Current Medical Research and Opinion 27:sup3, pages 73-84.
Read now

Articles from other publishers (16)

Georgios S. Papaetis. (2022) Pioglitazone, Bladder Cancer, and the Presumption of Innocence. Current Drug Safety 17:4, pages 294-318.
Crossref
Takayoshi Sasako, Kohjiro Ueki, Kana Miyake, Yukiko Okazaki, Yasuhiro Takeuchi, Yasuo Ohashi, Mitsuhiko Noda & Takashi Kadowaki. (2021) Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study. The Journal of Clinical Endocrinology & Metabolism 106:5, pages e2116-e2128.
Crossref
Suetonia C Palmer, Britta Tendal, Reem A Mustafa, Per Olav Vandvik, Sheyu Li, Qiukui Hao, David Tunnicliffe, Marinella Ruospo, Patrizia Natale, Valeria Saglimbene, Antonio Nicolucci, David W Johnson, Marcello Tonelli, Maria Chiara Rossi, Sunil V Badve, Yeoungjee Cho, Annie-Claire Nadeau-Fredette, Michael Burke, Labib I Faruque, Anita Lloyd, Nasreen Ahmad, Yuanchen Liu, Sophanny Tiv, Tanya Millard, Lucia Gagliardi, Nithin Kolanu, Rahul D Barmanray, Rita McMorrow, Ana Karina Raygoza Cortez, Heath White, Xiangyang Chen, Xu Zhou, Jiali Liu, Andrea Flores Rodríguez, Alejandro Díaz González-Colmenero, Yang Wang, Ling Li, Surya Sutanto, Ricardo Cesar Solis, Fernando Díaz González-Colmenero, René Rodriguez-Gutierrez, Michael Walsh, Gordon Guyatt & Giovanni F M Strippoli. (2021) Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ, pages m4573.
Crossref
Mahmoud M. Sirdah & N. Scott Reading. (2020) Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes. Clinical Genetics 98:6, pages 525-547.
Crossref
Binayak Sinha & Samit Ghosal. (2020) Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials. Scientific Reports 10:1.
Crossref
Peter Willeit, Lena Tschiderer, Elias AllaraKathrin ReuberLisa SeekircherLu GaoXiming LiaoEva LonnHertzel C. GersteinSalim YusufFrank P. BrouwersFolkert W. AsselbergsWiek van GilstSigmund A. AnderssenDiederick E. GrobbeeJohn J.P. KasteleinFrank L.J. VisserenGeorge Ntaios, Apostolos I. HatzitoliosChristos SavopoulosPythia T. Nieuwkerk, Erik StroesMatthew Walters, Peter Higgins, Jesse Dawson, Paolo GreseleGiuseppe Guglielmini, Rino MigliacciMarat EzhovMaya Safarova, Tatyana BalakhonovaEiichi SatoMayuko AmahaTsukasa NakamuraKostas KapellasLisa M. JamiesonMichael Skilton, James A. BlumenthalAlan HinderliterAndrew Sherwood, Patrick J. SmithMichiel A. van Agtmael, Peter ReissMarit G.A. van VonderenStefan Kiechl, Gerhard Klingenschmid, Matthias SitzerCoen D.A. Stehouwer, Heiko UthoffZhi-Yong ZouAna R. Cunha, Mario F. Neves, Miles D. WithamHyun-Woong Park, Moo-Sik LeeJang-Ho BaeEnrique Bernal, Kristian WachtellSverre E. Kjeldsen, Michael H. OlsenDavid Preiss, Naveed SattarEdith BeishuizenMenno V. HuismanMark A. EspelandCaroline SchmidtStefan AgewallErcan OkGülay AşçiEric de GrootMuriel P.C. GrootemanPeter J. BlankestijnMichiel L. BotsMichael J. SweetingSimon G. ThompsonMatthias W. Lorenz. (2020) Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk. Circulation 142:7, pages 621-642.
Crossref
Yue Zhou, Yajing Huang, Xiaoyun Ji, Xiang Wang, Liyan Shen & Yangang Wang. (2020) Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 105:5, pages 1670-1681.
Crossref
Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin & François Gueyffier. (2019) GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis. PLOS ONE 14:6, pages e0217701.
Crossref
Paola Portillo-Sanchez, Fernando Bril, Romina Lomonaco, Diana Barb, Beverly Orsak, Jan Marie Bruder & Kenneth Cusi. (2019) Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial. Journal of Diabetes 11:3, pages 223-231.
Crossref
H Yokoyama, S Araki, K Kawai, K Hirao, M Oishi, K Sugimoto, H Sone, H Maegawa & A Kashiwagi. (2015) Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36). Diabetes Research and Clinical Practice 109:3, pages 485-492.
Crossref
Frances StringerJoost DeJonghKazuaki EnyaEmiko KoumuraMeindert DanhofKohei Kaku. (2015) Evaluation of the Long-Term Durability and Glycemic Control of Fasting Plasma Glucose and Glycosylated Hemoglobin for Pioglitazone in Japanese Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 17:3, pages 215-223.
Crossref
Zhong-Ning Zhu, Yun-Fa Jiang & Tao Ding. (2014) Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials. Bone 68, pages 115-123.
Crossref
Kohei Kaku. (2014) 8. Progress in Treatment of Diabetes. Nihon Naika Gakkai Zasshi 103:9, pages 2275-2281.
Crossref
Toshiyuki Kokuryo, Kenichiro Hayashi & Masayuki Yamakawa. (2013) Study of Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in Patients with Type 2 Diabetes Mellitus. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 39:5, pages 309-321.
Crossref
Kohei Kaku & Mitsuru Hashiramoto. (2011) Thiazolidinediones and bone fractures. Journal of Diabetes Investigation 2:5, pages 354-355.
Crossref
Yoshimitsu Yamasaki, Naoto Katakami, Shigetaka Furukado, Kazuo Kitagawa, Kazuyuki Nagatsuka, Atsunori Kashiwagi, Hiroyuki Daida, Ryuzo Kawamori & Kohei Kaku. (2010) Long-Term Effects of Pioglitazone on Carotid Atherosclerosis in Japanese Patients with Type 2 Diabetes without a Recent History of Macrovascular Morbidity. Journal of Atherosclerosis and Thrombosis 17:11, pages 1132-1140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.